• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于治疗伴侣动物皮肤致病性真菌及其他真菌的抗菌策略:一项叙述性综述

Antimicrobial Strategies Proposed for the Treatment of and Other Dermato-Pathogenic spp. in Companion Animals: A Narrative Review.

作者信息

Stefanetti Valentina, Passamonti Fabrizio, Rampacci Elisa

机构信息

Department of Human Science and Promotion of Quality Life, San Raffaele Telematic University, 00166 Rome, Italy.

Department of Veterinary Medicine, University of Perugia, Via San Costanzo 4, 06126 Perugia, Italy.

出版信息

Vet Sci. 2024 Jul 11;11(7):311. doi: 10.3390/vetsci11070311.

DOI:10.3390/vetsci11070311
PMID:39057995
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11281426/
Abstract

The treatment of dermato-pathogenic spp., particularly , in companion animals presents significant challenges due to rising antimicrobial resistance. This review explores innovative strategies to combat these infections. We examined novel antimicrobials and the repurposing of existing drugs to enhance their efficacy against resistant strains. Additionally, we evaluate the potential of natural products, nanomaterials, and skin antiseptics as alternative treatments. The review also investigates the use of antimicrobial peptides and bacteriophages, highlighting their targeted action against staphylococcal pathogens. Furthermore, the role of adjuvants in antibiotic treatments, such as antimicrobial resistance breakers, is discussed, emphasizing their ability to enhance therapeutic outcomes. Our analysis underscores the importance of a multifaceted approach in developing effective antimicrobial strategies for companion animals, aiming to mitigate resistance and improve clinical management of staphylococcal skin infections.

摘要

由于抗菌药物耐药性不断上升,治疗伴侣动物的皮肤致病性物种,尤其是[此处原文缺失具体物种]面临着重大挑战。本综述探讨了对抗这些感染的创新策略。我们研究了新型抗菌药物以及现有药物的重新利用,以提高它们对耐药菌株的疗效。此外,我们评估了天然产物、纳米材料和皮肤防腐剂作为替代治疗方法的潜力。该综述还研究了抗菌肽和噬菌体的使用,强调了它们对葡萄球菌病原体的靶向作用。此外,还讨论了佐剂在抗生素治疗中的作用,如抗菌耐药性突破剂,强调了它们提高治疗效果的能力。我们的分析强调了采取多方面方法制定有效的伴侣动物抗菌策略的重要性,旨在减轻耐药性并改善葡萄球菌皮肤感染的临床管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/11281426/9e51006337e3/vetsci-11-00311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/11281426/9e51006337e3/vetsci-11-00311-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/57fe/11281426/9e51006337e3/vetsci-11-00311-g001.jpg

相似文献

1
Antimicrobial Strategies Proposed for the Treatment of and Other Dermato-Pathogenic spp. in Companion Animals: A Narrative Review.用于治疗伴侣动物皮肤致病性真菌及其他真菌的抗菌策略:一项叙述性综述
Vet Sci. 2024 Jul 11;11(7):311. doi: 10.3390/vetsci11070311.
2
Antimicrobial activity of α-mangostin against species from companion animals and therapeutic potential of α-mangostin in skin diseases caused by .α-倒捻子素对来自伴侣动物的 种的抗菌活性及α-倒捻子素在 引起的皮肤病中的治疗潜力
Front Cell Infect Microbiol. 2023 May 25;13:1203663. doi: 10.3389/fcimb.2023.1203663. eCollection 2023.
3
Antibacterial Characterization of Novel Synthetic Thiazole Compounds against Methicillin-Resistant Staphylococcus pseudintermedius.新型合成噻唑化合物对耐甲氧西林中间型葡萄球菌的抗菌特性
PLoS One. 2015 Jun 18;10(6):e0130385. doi: 10.1371/journal.pone.0130385. eCollection 2015.
4
Combined antimicrobial effect of two peptide nucleic acids against and veterinary isolates.两种肽核酸对[具体名称未给出]和兽医分离株的联合抗菌作用。
J Vet Sci. 2024 Jan;25(1):e12. doi: 10.4142/jvs.23265.
5
Antibacterial activity of novel cationic peptides against clinical isolates of multi-drug resistant Staphylococcus pseudintermedius from infected dogs.新型阳离子肽对感染犬多药耐药中间型葡萄球菌临床分离株的抗菌活性
PLoS One. 2014 Dec 31;9(12):e116259. doi: 10.1371/journal.pone.0116259. eCollection 2014.
6
Genetic diversity and antimicrobial resistance profiles of associated with skin and soft-tissue infections in companion animals in Lisbon, Portugal.葡萄牙里斯本伴侣动物皮肤和软组织感染相关的遗传多样性和抗菌药物耐药性概况。
Front Microbiol. 2023 Apr 17;14:1167834. doi: 10.3389/fmicb.2023.1167834. eCollection 2023.
7
In vitro and in vivo antibacterial studies of volatile oil from Atractylodis Rhizoma against Staphylococcus pseudintermedius and multidrug resistant Staphylococcus pseudintermedius strains from canine pyoderma.苍术挥发油对犬脓皮病中间葡萄球菌及其多重耐药株的体外与体内抗菌研究。
J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117326. doi: 10.1016/j.jep.2023.117326. Epub 2023 Oct 23.
8
Lytic Activity of Polyvalent Staphylococcal Bacteriophage PhiSA012 and Its Endolysin Lys-PhiSA012 Against Antibiotic-Resistant Staphylococcal Clinical Isolates From Canine Skin Infection Sites.多价葡萄球菌噬菌体PhiSA012及其内溶素Lys-PhiSA012对犬皮肤感染部位抗生素耐药性葡萄球菌临床分离株的裂解活性
Front Med (Lausanne). 2020 Jun 10;7:234. doi: 10.3389/fmed.2020.00234. eCollection 2020.
9
Anti-Staphylococcal Activity of SWLA-1 and Its Supernatant against Multidrug-Resistant in Novel Rat Model of Acute Osteomyelitis.SWLA-1及其上清液在新型大鼠急性骨髓炎模型中对多重耐药菌的抗葡萄球菌活性
Antibiotics (Basel). 2023 Sep 13;12(9):1444. doi: 10.3390/antibiotics12091444.
10
Multidrug-Resistant Commensal and Infection-Causing spp. Isolated from Companion Animals in the Valencia Region.从巴伦西亚地区伴侣动物中分离出的耐多药共生菌和致病菌株。
Vet Sci. 2024 Jan 26;11(2):54. doi: 10.3390/vetsci11020054.

引用本文的文献

1
Antibacterial Activity of Clove Essential Oil () Against Oxacillin-Resistant Isolated from Dogs with Otitis Externa.丁香精油对从患有外耳炎的犬只分离出的耐氧西林金黄色葡萄球菌的抗菌活性
Pathogens. 2025 Jul 17;14(7):709. doi: 10.3390/pathogens14070709.
2
Metabolomic profiling and antibacterial efficacy of probiotic-derived cell-free supernatant encapsulated in nanostructured lipid carriers against canine multidrug-resistant bacteria.纳米结构脂质载体包裹的益生菌无细胞上清液的代谢组学分析及其对犬多药耐药菌的抗菌效果
Front Vet Sci. 2025 Jan 3;11:1525897. doi: 10.3389/fvets.2024.1525897. eCollection 2024.

本文引用的文献

1
Efficiency of NZ2114 on Superficial Pyoderma Infected with .NZ2114对感染……的浅表脓皮病的疗效
Pharmaceuticals (Basel). 2024 Feb 22;17(3):277. doi: 10.3390/ph17030277.
2
Clinical safety and efficacy of a single-dose gentamicin, posaconazole and mometasone furoate otic suspension for treatment of canine otitis externa.一种单剂量庆大霉素、泊沙康唑和糠酸莫米松耳用混悬剂治疗犬外耳炎的临床安全性和疗效。
Vet Rec. 2024 May 4;194(9):e3955. doi: 10.1002/vetr.3955. Epub 2024 Mar 10.
3
Antibacterial Potential of Essential Oils and Silver Nanoparticles against Multidrug-Resistant Isolates.
精油和银纳米颗粒对多重耐药菌株的抗菌潜力
Pathogens. 2024 Feb 9;13(2):156. doi: 10.3390/pathogens13020156.
4
In Vitro Activity of Organosulfur Derivatives against Canine Multidrug-Resistant Strains of spp. and .有机硫衍生物对犬源耐多药菌株的体外活性 (注:原文中“ spp. and.”表述不完整,可能影响准确理解其完整意思。)
Vet Sci. 2024 Jan 9;11(1):26. doi: 10.3390/vetsci11010026.
5
In vitro evaluation of bactericidal effects of fluorescent light energy on Staphylococcus pseudintermedius and S. aureus.体外评估荧光光能对中间葡萄球菌和金黄色葡萄球菌的杀菌效果。
Vet Dermatol. 2024 Apr;35(2):166-174. doi: 10.1111/vde.13235. Epub 2024 Jan 4.
6
NLRP3 inhibitors: Unleashing their therapeutic potential against inflammatory diseases.NLRP3 抑制剂:释放其在炎症性疾病治疗中的潜力。
Biochem Pharmacol. 2023 Dec;218:115915. doi: 10.1016/j.bcp.2023.115915. Epub 2023 Nov 8.
7
In vitro and in vivo antibacterial studies of volatile oil from Atractylodis Rhizoma against Staphylococcus pseudintermedius and multidrug resistant Staphylococcus pseudintermedius strains from canine pyoderma.苍术挥发油对犬脓皮病中间葡萄球菌及其多重耐药株的体外与体内抗菌研究。
J Ethnopharmacol. 2024 Jan 30;319(Pt 3):117326. doi: 10.1016/j.jep.2023.117326. Epub 2023 Oct 23.
8
Anti-Staphylococcal Activity of SWLA-1 and Its Supernatant against Multidrug-Resistant in Novel Rat Model of Acute Osteomyelitis.SWLA-1及其上清液在新型大鼠急性骨髓炎模型中对多重耐药菌的抗葡萄球菌活性
Antibiotics (Basel). 2023 Sep 13;12(9):1444. doi: 10.3390/antibiotics12091444.
9
Comparison between clinical evaluations and laboratory findings and the impact of biofilm on antimicrobial susceptibility in vitro in canine otitis externa.犬外耳炎的临床评估与实验室检查结果的比较及生物膜对体外抗菌药物敏感性的影响。
Vet Dermatol. 2023 Dec;34(6):586-596. doi: 10.1111/vde.13197. Epub 2023 Aug 14.
10
Antimicrobial Activity of Aqueous Extract against Sensitive and Resistant Bacterial Strains.水提取物对敏感和耐药菌株的抗菌活性。
Microorganisms. 2023 Jul 10;11(7):1784. doi: 10.3390/microorganisms11071784.